Cardinal Health 414, LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$4.5M
Doctors Paid
1,041
Transactions
2,247
2024 Total
$474,461
Payment Breakdown by Category
Consulting$1.7M (38.2%)
Research$924,847 (20.7%)
Travel$87,438 (2.0%)
Food & Beverage$38,034 (0.8%)
Royalty/License$11,750 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.7M | 359 | 38.2% |
| Space rental or facility fees (teaching hospital only) | $1.6M | 182 | 36.4% |
| Unspecified | $924,847 | 58 | 20.7% |
| Travel and Lodging | $87,438 | 329 | 2.0% |
| Food and Beverage | $38,034 | 1,251 | 0.8% |
| Education | $30,949 | 8 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,051 | 55 | 0.6% |
| Grant | $18,680 | 4 | 0.4% |
| Royalty or License | $11,750 | 1 | 0.3% |
Payments by Type
General
$3.6M
2,189 transactions
Research
$924,847
58 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Randomized phase II/III trial of versus elective neck dissection for early-stage oral cavity cancer | $351,737 | 0 | 4 |
| Randomized phase II/III trial of sentinel lymph node biopsy | $189,067 | 0 | 1 |
| Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer | $122,447 | 0 | 2 |
| NAV3-18 | $109,736 | 0 | 22 |
| A single center, open-label study evaluating the ability of 99mTc-tilmanocept to identify clippped nodes in breast cancer patients undergoing neoadjuvant chemotherapy and sentinel lymph node assessment | $53,347 | 0 | 9 |
| A randomized controlled double-blinded study comparing the intraoperative injection | $21,580 | 0 | 2 |
| A Phase II Investigation of Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer Patients Managed with Primary (Chemo) Radiation | $17,846 | 0 | 4 |
| NAV3-19 | $15,708 | 0 | 6 |
| A randomized controlled double-blinded study comparing the intraoperative injection of lymphatic mapping agents | $12,626 | 0 | 2 |
| A Single Center, Open-Label StudyEvaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer PatientsUndergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Assessment | $11,595 | 0 | 1 |
| Retrospective Comparison Evaluating Sulfur Colloid versus Lymphoseek in a Clinical Setting | $8,559 | 0 | 2 |
| A randomized controlled double-blinded study comparing the intraoperative injection of lymphatic mapping agents Tc 99m tilmanocept to Tc 99m filtered sulfur colloid in breast cancer patients undergoing breast conservation and sentinel lymph node biopsy | $7,150 | 0 | 1 |
| A Prospective Randomized Parallel Group Double-Blinded Clinical Trial | $3,449 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Michael Blue, M.d, M.D | Emergency Medicine | Lone Pine, CA | $1.2M | $0 |
| Dr. Charles Intenzo, M.d, M.D | Diagnostic Radiology | Philadelphia, PA | $88,014 | $0 |
| Dr. Linda Han, M.d, M.D | Surgery | Germantown, TN | $83,436 | $0 |
| Dr. Stephen Lai, Md,Phd, MD,PHD | Otolaryngology | Houston, TX | $67,096 | $0 |
| Unknown Provider | — | — | $55,196 | $0 |
| Vincent Reid, M.d, M.D | Surgery | Cedar Rapids, IA | $31,999 | $0 |
| Charles Cox, Md, MD | Surgical Oncology | Tampa, FL | $30,240 | $0 |
| Laura Lawson, Md, MD | Surgery | Nashville, TN | $14,490 | $0 |
| John Vetto, Md, MD | Surgery | Portland, OR | $11,131 | $0 |
| Mr. Brian Gastman, Md, MD | Otolaryngology | Cleveland, OH | $11,109 | $0 |
| Henry Kuerer, M.d, M.D | Surgical Oncology | Houston, TX | $11,095 | $0 |
| Rache Simmons, M.d, M.D | Surgery | New York, NY | $10,881 | $0 |
| Irene Wapnir, M.d, M.D | Surgical Oncology | Palo Alto, CA | $10,289 | $0 |
| Dr. Maggie Dinome, M.d, M.D | Surgery | Los Angeles, CA | $10,240 | $0 |
| Dr. Georgia Beasley, M.d, M.D | Surgical Oncology | Durham, NC | $9,010 | $0 |
| Bret Taback, M.d, M.D | Surgery | New York, NY | $8,998 | $0 |
| Dr. Gary Kay, M.d, M.D | Hematology & Oncology | Elk Grove Village, IL | $8,950 | $0 |
| Dr. Alene Wright, M.d, M.D | Surgery | Trinity, FL | $7,196 | $0 |
| Dr. William Lavigne, M.d, M.D | Obstetrics & Gynecology | Augusta, GA | $6,424 | $0 |
| Dr. Stanley Leong, Md, MD | Surgical Oncology | San Francisco, CA | $5,390 | $0 |
| Dr. Wei Lin, Md, MD | Internal Medicine | Cloquet, MN | $5,270 | $0 |
| Dr. Stacy Krisher, Md, MD | Surgical Oncology | Bensalem, PA | $4,900 | $0 |
| Dr. Linsey Gold, Do, DO | Surgery | Flint, MI | $4,900 | $0 |
| Calvin Ridgeway, Md, MD | Surgery | Albuquerque, NM | $4,900 | $0 |
| Mitchell Chorost, M.d, M.D | Surgical Oncology | Fresh Meadows, NY | $4,900 | $0 |
Ad
Top Products
- Lymphoseek $880,381
- KIT FOR THE PREPARATION OF LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) $788,732
Associated Products (1)
Payment Categories
- Food & Beverage $38,034
- Consulting $1.7M
- Travel & Lodging $87,438
- Research $924,847
- Royalties $11,750
About Cardinal Health 414, LLC
Cardinal Health 414, LLC has made $4.5M in payments to 1,041 healthcare providers, recorded across 2,247 transactions in the CMS Open Payments database. In 2024, the company paid $474,461. The top product by payment volume is Lymphoseek ($880,381).
Payments were distributed across 64 medical specialties. The top specialty by payment amount is Emergency Medicine ($1.2M to 3 doctors).
Payment categories include: Food & Beverage ($38,034), Consulting ($1.7M), Research ($924,847), Travel & Lodging ($87,438), Royalties ($11,750).
Cardinal Health 414, LLC is associated with 1 products in the CMS Open Payments database.